Catalent Stock Flat Following the Sell Agreement With Ardena
CTLT announces an agreement to sell its oral solids development and manufacturing facility in Somerset to Ardena.
Catalent to Sell Somerset Oral Solids Facility to Ardena
Catalent entered into a definitive agreement to sell its oral solids development and small-scale manufacturing facility in Somerset to Ardena
Catalent to sell New Jersey facility
Catalent has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug manufacturer Ardena, the companies said on Monday. Catalent provides contract manufacturing services and performs fill-finish work,
Catalent to sell Somerset HQ
The site also serves as an oral solids development and small-scale manufacturing facility for the pharmaceutical company, which is in talks with Novo Holdings for a $16.5 billion acquisition.
Catalent to sell Somerset oral solids facility
Catalent (NYSE:CTLT) is selling its oral solids development and small-scale manufacturing facility in Somerset, New Jersey to contract manufacturer Ardena. Financial details of the agreement, which is expected to close in early 2025,
Catalent To Sell Oral Solids Development Facility In Somerset, NJ To Ardena
Catalent, Inc. (CTLT), a provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer
Ardena inks agreement to acquire Catalent’s state-of-the-art facility in Somerset, New Jersey
Ardena inks agreement to acquire Catalent’s state-of-the-art facility in Somerset, New Jersey: Ghent, Belgium Tuesday, October 15, 2024, 16:00 Hrs [IST] Ardena, a specialist pha
Ardena Signs Agreement to Expand US Footprint with the Acquisition of Advanced Drug Product Manufacturing Facility from Catalent
Somerset facility State-of-the art facility for clinical and commercial manufacturing of oral dosage forms. Ghent, Belgium, ...
FiercePharma3d
Catalent offloads New Jersey manufacturing plant, HQ to Belgian CDMO Ardena
Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...
Outsourcing-pharma15d
Ardena debuts new nanomedicines facility at CPHI 2024
At CPHI Milan 2024, Ardena will showcase its latest advancements in drug development and manufacturing, including the launch ...
Reuters7d
New Jersey News | Today's Latest Stories | Reuters
Catalent has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug manufacturer Ardena, the companies said on Monday.
The New York Times1d
World News
In the 1990s, China began sending pandas to foreign zoos to be bred, in the hope that future generations could be released into the wild. It hasn’t gone as planned. By Mara Hvistendahl and Joy ...
Outsourcing-pharma9d
Small molecules in focus as Recipharm bolsters global production facilities
Months after divesting seven European sites, the Swedish contract development and manufacturing organisation (CDMO) Recipharm ...